Insights

Strategic Focus Cure Ventures specializes in forming new companies around curative technologies with strong IP positions and mechanistic biological clarity, indicating potential partnerships around early-stage company creation, due diligence collaboration, and co-building opportunities.

Funding Readiness As a venture capital and private equity principal with recent Series A investments in Tasca Therapeutics and Kenai Therapeutics, Cure Ventures demonstrates active allocation of sizable capital to biotech start-ups, signaling potential for co-investment rounds, follow-on funding, and deal syndication.

Strategic Partnerships The firm emphasizes expedited clinical routes and large pharmaceutical partnering interest, suggesting opportunities to pitch programs aligned with big pharma collaboration, licensing deals, and strategic co-development arrangements.

Market Validation Success metrics include multiple high unmet patient needs, diverse commercial applications, and a strong scientific provenance, indicating a buyer-friendly profile for solutions with clear exit strategies and scalable markets.

Operational Readiness Current tech stack and engagement with corporate tools imply a modern, scalable operating model; sales opportunities could target Cure Ventures for enterprise solutions, compliance, and secure collaboration platforms to support portfolio company operations.

Similar companies to Cure Ventures

Cure Ventures Tech Stack

Cure Ventures uses 8 technology products and services including WordPress, CookieYes, Shopify, and more. Explore Cure Ventures's tech stack below.

Cure Ventures's Email Address Formats

Cure Ventures uses at least 2 email formats:
Cure Ventures Email FormatsExamplePercentage
FLast@curevc.comJDoe@curevc.com
91%
First.Last@curevc.comJohn.Doe@curevc.com
9%

Frequently Asked Questions

What is Cure Ventures's official website and social media links?

Minus sign iconPlus sign icon
Cure Ventures's official website is curevc.com and has social profiles on LinkedIn.

How much revenue does Cure Ventures generate?

Minus sign iconPlus sign icon
As of September 2026, Cure Ventures's annual revenue is estimated to be $10M - $25M.

What is Cure Ventures's NAICS code?

Minus sign iconPlus sign icon
Cure Ventures's NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Cure Ventures have currently?

Minus sign iconPlus sign icon
As of September 2026, Cure Ventures has approximately 19 employees across 1 continents, including North America. Key team members include Chief Technology Officer, Partner: B. A., Managing Partner And Co-Founder: L. T. and Managing Partner And Co-Founder: R. L. Explore Cure Ventures's employee directory with LeadIQ.

What industry does Cure Ventures belong to?

Minus sign iconPlus sign icon
Cure Ventures operates in the Venture Capital and Private Equity Principals industry.

What technology does Cure Ventures use?

Minus sign iconPlus sign icon
Cure Ventures's tech stack includes WordPress, CookieYes, Shopify, Mimecast Secure Email Gateway, Brevo, DocuSign, Vimeo and Piwik PRO Core.

What is Cure Ventures's email format?

Minus sign iconPlus sign icon
Cure Ventures's email format typically follows the pattern of FLast@curevc.com. Find more Cure Ventures email formats with LeadIQ.

When was Cure Ventures founded?

Minus sign iconPlus sign icon
Cure Ventures was founded in 2020.
Cure Ventures logo

Cure Ventures

Venture Capital and Private Equity PrincipalsMassachusetts, United States11-50 Employees

Cure Ventures is a venture capital and private equity firm based in Boston, Massachusetts, that concentrates on creating new companies around curative technologies. The firm emphasizes de novo company formation, developing ventures around bold ideas and scientists-entrepreneurs. It leverages its team's deep experience in building companies to tailor the amount and type of capital to each stage of a venture's life cycle. The focus is on disruptive scientific solutions with strong intellectual property, aiming to address unmet patient needs and pursue high-impact diseases.

In pursuing effective company builds, Cure Ventures looks for ventures with solid genetic validation and rigorously derived scientific data tied to a distinguished laboratory, clear mechanistic biology, and multiple commercial applications. It also prioritizes large, relatively untapped markets, streamlined clinical development pathways, and active partnership interest from large pharmaceutical companies, along with a defined path toward an exit.

Section iconCompany Overview

Website
curevc.com
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Cure Ventures's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.